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Abstract
Type 2 asparaginases, a subfamily of N-terminal nucleophile (Ntn) hydrolases, are acti-
vated by limited proteolysis. This activation yields a heterodimer and a loop region at the C-
terminus of the α-subunit is released. Since this region is unresolved in all type 2 asparagi-
nase crystal structures but is close to the active site residues, we explored this loop region
in six members of the type 2 asparaginase family using homology modeling. As the loop
model for the childhood cancer-relevant protease Taspase1 differed from the other mem-
bers, Taspase1 activation as well as the conformation and dynamics of the 56 amino acids
loop were investigated by CD and NMR spectroscopy. We propose a helix-turn-helix motif,
which can be exploited as novel anticancer target to inhibit Taspase1 proteolytic activity.
Introduction
Proteolysis is a common regulatory process governing several essential pathways such as apo-
ptosis [1] or blood clotting [2]. In contrast to protein digestion and degradation, proteolytic
activation events occur in a site-specific manner and induce a conformational change that
increases the catalytic activity significantly [3]. This type of regulation is common for proteases,
but is also found among N-terminal nucleophile (Ntn) hydrolases involved in diverse cellular
processes.
Ntn hydrolases are typically activated from an enzymatically inactive zymogen by hydrolysis
of the peptide bond N-terminal of the active site residue. This intramolecular reaction occurs
spontaneously and the new N-terminal amino acid (serine, threonine or cysteine) becomes the
active site residue, located at the beginning of a β-strand [4,5]. Despite low sequence homology,
diverse substrate specificity and functions, all Ntn hydrolases share a common αββα-asparagi-
nase fold.
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One subfamily of Ntn hydrolases is represented by type 2 asparaginase proteins, which com-
prise three different types of enzymes: (i) asparaginases convert L-asparagine to L-aspartate, (ii)
glycosylasparaginases are involved in the degradation of glycoproteins, as they remove N-acet-
ylglucosamine attached to asparagine, and (iii) threonine aspartase 1 (Taspase1) is a threonine
protease responsible for the activation of the mixed lineage leukemia (MLL) protein involved
in childhood leukemias [6], and regulates transcription factor IIa (TFIIa) [7].
Usually, inhibitory propeptides are completely removed during enzyme activation [8,9].
However, this is not the case for the above mentioned members of type 2 asparaginases [10–
14], in which the activation releases a loop region at the C-terminus of the α-subunit. This loop
comprises 10 to 56 amino acids and is not resolved in any type 2 asparaginase crystal structure
due to a lack of electron density for this region, indicating high flexibility [10–14].
Essentially, the close proximity to the active site of this unresolved region and especially its
crucial role for the activation of the cancer-related protease Taspase1 characterizes this region
as a novel target for Taspase1 inhibition. The applicability as drug target is further underlined,
since it comprises a nuclear localization signal (NLS), which was predicted in silico and con-
firmed in vivo [15]. Other type 2 asparaginase proteins, however, do not exhibit this NLS
according to the sequence-based PredictNLS algorithm [16]. Indeed, these proteins were exper-
imentally found in the periplasm (E. coli asparaginase and F.meningosepticum glycosylaspara-
ginase [17]), the cytoplasm (human asparaginase; [18]) or lysosomes (human
glycosylasparaginase; [19]).
As Taspase1 inhibitors have been reported to reduce breast cancer growth in mice [20], Tas-
pase1 inhibitors have a promising potential in general cancer treatment. Here, we investigate
the structure of six type 2 asparaginase loops at the C-terminus of the α-subunit in silico and
present a spectroscopy supported model of this region in Taspase1.
Material and Methods
Secondary structure prediction
Secondary structure was predicted based on the protein sequence of human Taspase1 (RefSeq
NP_060184.2) using Jpred [21], the Chou-Fasman algorithm (CFSSP; [22]), and the YASARA
algorithm with default parameters.
Homology modeling and molecular dynamics (MD) simulations
Homology models including also flexible amino acids of the loop and the termini were gener-
ated with the YASARA Structure suite applying the parameters listed in S1 Table using the pro-
enzyme crystal structures as templates. Unless otherwise described, the full amino acid
sequence was used as query, therefore generating the proenzymes before proteolytic activation.
The open state model of Taspase1 was obtained by modeling the two subunits with subsequent
energy minimization of the resulting heterodimer. Three 10 ns all atoms molecular dynamics
simulations of the Taspase1 loop fragment were performed applying a YAMBER3 [23],
YASARA2 [24], or AMBER03 [25] force field with the YASARA Structure suite in a cubic sim-
ulation cell with 17.3 nm length and periodic boundaries. After energy minimization and simu-
lated annealing (2 fs steps atom velocities scaled down to 90% every 20 fs; convergence with
less than 0.05 kJ/mol per atom during 200 steps), MD simulations were started using default
parameters and drift correction (1 fs time steps; 25°C; 0.8 nm Coulomb and van der Waals
interactions cut off; particle-mesh Ewald calculations for long range Coulomb interactions; no
angle or bond constraints). Open state loops of the regions missing in the active Taspase1 crys-
tal structure PDB 2a8j and the respective regions in the homologous type 2 asparaginases were
modelled using the YASARA algorithm for loop building. In short, the algorithm searches a
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non-redundant subset of the protein data bank for homologous sequences and extracts their
conformations. These conformations were ranked for quality, fitted to the anchor points and
the side chains were optimized. Ten models were generated per template to evaluate different
possible conformations. Statistics for the secondary structure of the ten models are given in the
main text and the top-ranked conformation was chosen for visualization in Fig 1.
Cloning, protein expression and purification
His-tagged wild-type Taspase1 was cloned, expressed and purified as described before [26].
After expression in E. coli strain BL21(DE3)T1r in 4 l minimal medium (M9), supplemented
with 15NH4Cl and/or
13C-glucose, for 6 h at 30°C, the soluble protein fraction after sonication
and ultracentrifugation was loaded onto a HisTrap HP 5 ml Ni-NTA column (GE Healthcare,
Munich, Germany) equilibrated with 50 mMNaH2PO4, pH 8.0, 450 mMNaCl, 10 mM imid-
azole. Fractions after imidazole elution containing Taspase1 were gel filtrated on a Superdex
200 HiLoad 16/600 column (GE Healthcare). Finally, fractions from the size exclusion chroma-
tography containing Taspase1 were concentrated to 18 mg/ml.
The Taspase1 loop (Gly178-Asp233) was amplified by PCR (forward primer: 5'-CACACA
GGGCCCGGAATACCGTCTTGCCCTCC; reverse primer: 5'-GGTTGGCTCGAGCTTAGTCCAAA
GTGCCTGAGTCGTTC) and ApaI/XhoI-cloned into a modified pET41b vector containing an
N-terminal GST tag and a PreScission protease cleavage site [27]. After expression in E. coli
BL21(DE3)T1r at 25°C overnight, the soluble protein fraction after sonication and ultracentri-
fugation was loaded onto a 20 ml GSTrap column (GE Healthcare) equilibrated with 50 mM
NaH2PO4, pH 7.0, 450 mMNaCl, 1 mM DTT, 1% Triton X-100. Protein containing fractions
after glutathione elution were pooled and the GST-tag was cleaved off by incubation with Pre-
Scission protease (1 μg/mg fusion protein) overnight at 4°C. Separation of the GST-tag from
the inhibitory peptide fragment was done by filtration through a membrane with 10 kDa cut
off. The flow through containing the inhibitory peptide fragment was concentrated to 7 mg/ml.
NMR spectroscopy
NMR spectra were recorded with a 700 MHz UltraShield NMR spectrometer (Bruker, Rhein-
stetten, Germany) equipped with a cryoprobe (Bruker Biospin). Samples contained 600 μM
Taspase1 in 600 μl 50 mMNaH2PO4, pH 7.9, 300 mMNaCl, 1 mM DTT buffer supplemented
with 2% D2O. Spectra for assignment of the full-length Taspase1 (
1H-15N HSQC, HBHANH,
HBHACONH, HNCA, HNCACB, 1H-15N TOSCY-HSQC as well as HCCH-TOCSY) were
recorded at 30°C. For the 13C-15N-labelled Taspase1 loop (Gly178-Asp233; 150 μM in 50 mM
KH2PO4, pH 6.5, with 10% D2O),
1H-15N HSQC, HNCACB, CBCACONH and 1H-15N TOS-
CY-HSQC spectra were taken at 25°C. All spectra were referenced using DSS for 1H and
IUPAC for 13C and 15N [28]. Prior to processing a shifted sine-bell square window function for
apodization was used. Processing was done using the Topspin 3.0 software (Bruker). Peak
assignment was performed in CCPN and example sections of the 3D spectra used for chain
tracing are shown in S1 Fig.
CD spectroscopy
Far-UV CD spectra were recorded with a Jasco J-710 spectropolarimeter (Jasco, Gross-
Umstadt) with 0.15 mg/ml protein in 50 mMNaH2PO4, pH 7.9 buffer at 21°C in 1 mm
cuvettes. A buffer baseline was subtracted and units were converted to specific ellipticity. Sec-
ondary structure content was evaluated using the CDSSTR algorithm with the SDP48 reference
data set.
Taspase1 Loop Conformations
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Results
Asparaginase type 2 loop structure models
Homology models for the unresolved regions in six asparaginase type 2 proenzyme crystal
structures (generated with YASARA) suggest that helices can establish in the respective regions
(Fig 1). However, as these helices are typically short and occur only in a fraction of the loop
models for asparaginases (53%) and glycosylasparaginases (45%), they are presumably tran-
sient. In contrast, the Taspase1 loop (Gly178-Asp233) is predicted to form helices in all models.
Moreover, Taspase1 differs from other type 2 asparaginase family proteins in that its substrates
are polypeptide bonds instead of the modification of single amino acids and that it does not
cleave itself only but also acts as a protease in trans [6]. However, although Taspase1 holds a
special position among type 2 asparaginases, they all share a very high degree of structural
homology, especially with respect to the active site, and it is still unclear why only Taspase1 is
an active protease. Hence, investigating the loop region next to the catalytic site might help to
explain functional differences in the type 2 asparaginase family.
Interestingly, the amino acid sequence of the Taspase1 loop is highly conserved among Tas-
pase1 proteins from 32 species (S2 Fig), but does not occur in other proteins, as BLAST
searches retrieve only Taspase1 homologues, which indicates an essential and unique part of
the protein. Hence, we focused our analyses on the Taspase1 loop and investigated its
conformation.
Fig 1. Type 2 asparaginase loopmodels.Modeled structures of the Taspase1 loop homologous regions in other type 2 asparaginases generated with
YASARA. The loop of human Taspase1 (template PDB 2a8i; 25 modeled amino acids) is predicted as predominantly helical, while for human
glycosylasparaginase (template PDB 1apy; 20 modeled aa), human asparaginase (template PDB 4pvs; 14 modeled aa), plant asparaginase (template PDB
2gez; 33 modeled aa), E. coli asparaginase (template PDB 2zal; 17 modeled aa), and F.meningosepticum glycosylasparaginase (template PDB 1ayy; 10
modeled aa) mainly random coil elements are predicted. The modeled loop regions are highlighted in red; the active site (corresponding to Thr234 in
Taspase1) is highlighted in green.
doi:10.1371/journal.pone.0151431.g001
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Sequence-based secondary structure predictions of the Taspase1 loop suggest a helical con-
tent of around 50% (Fig 2). In particular, both N- and C-terminus are predicted as random coil
regions, while the central part (Asn185-Ser223) is mostly helical.
The Taspase1 loop adopts a helix-turn-helix conformation
To test Taspase1 loop predictions in vitro, we exploited NMR spectroscopy to obtain structural
data on this flexible region in the context of the full-length protein. Owing to the high molecu-
lar weight of Taspase1 forming a αββα-tetramer in solution (~90kDa) line broadening due to
high correlation time and high number of hydrogen atoms should lead to a disappearance of
most signals in a corresponding 1H-15N-HSQC spectrum. Only NH groups of very dynamic
regions such as loops and termini are expected to generate measurable peaks.
Hence, 56 peaks are visible in the 1H-15N HSQC spectrum of Taspase1, 32 of which were
assigned unambiguously (Fig 3 and S2 Table). The low 1H signal dispersion of 0.8 ppm typical
for intrinsically disordered proteins [29–31] indicates the absence of very rigid secondary
structure elements in the observed regions.
Remarkably, the amino acids whose signals are observed are predominantly located either
in the flexible N-terminus (15 residues) of Taspase1 or in the C-terminus (12 residues) of the
α-subunit. Whereas 1H-15N signals for residues C-terminal of Arg220 could be assigned, no
signals could be assigned to amino acids of the N-terminal part of the Taspase1 loop (Gly178
to Arg220). This indicates an interaction of this region to the protein core, probably due to the
occurrence of a more rigid secondary structure element N-terminal of Glu221 with an
increased rotational correlation time.
Furthermore, the increased flexibility of the Taspase1 loop upon cleavage is also reflected in
the time dependence of NMR spectra: Right after purification, only the strongest signals from
three amino acids (Glu226, Leu232, and Asp233) located in the loop are visible. This corre-
sponds to the low amount of activated Taspase1 and concomitantly on average a less flexible
loop. However, as activation proceeds, another nine signals from loop amino acids
(Ser222-Lys225 and Asn227-Thr231) become visible over seven days, which is not due to sim-
ple protein degradation (S3 Fig).
For further analyses, we expressed and purified a peptide covering all amino acids invisible
in the crystal structure of activated Taspase1 (pdb 2a8j; Gly178-Asp233). Far-UV CD spectra
of this peptide confirmed a significant helical content of 58%, which is in agreement with the
secondary structure prediction (Fig 4a and 4b). Additionally, a shorter synthetic peptide cover-
ing the predicted helical center of the loop only (Pro183-Ser222) still retains these helical ele-
ments (Fig 4a and 4b). Molecular dynamics simulations with different force fields indicate that
Fig 2. Secondary structure predictions of Taspase1 loop. Primary sequence based secondary structure predictions of the loop region Gly178-Asp233 of
Taspase1, which is missing in the crystal structure of active Taspase1 (PDB 2a8j). The algorithms predict a stretch of helices between Asn185 and Ser223.
For the YASARAmodel and the JNet prediction, cylinders represent helical areas, lines represent random coil and loops are represented as curves.
Confidence (conf) values range from 0 (uncertain) to 9 (confident). Residues predicted as buried by sol25 and sol0 are labeled (B).
doi:10.1371/journal.pone.0151431.g002
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especially the second helix (around Leu216) forms only transiently in the short peptide (Fig 4c
and 4d). Moreover, the simulations suggest that the stretch around Arg190 (first helix) is most
prone to helix formation, while the terminal regions of the loop remained without any second-
ary structure elements. Importantly, the central part around Ala206 between the two helices
formed a turn motif in all three simulations.
Fig 3. 1H-15N HSQC of full-length Taspase1. 1H-15N HSQC spectrum of full-length Taspase1 after one week at 30°C. The crowded region in the center of
the spectrum (dashed lines) is magnified. For amino acids labeled with letters without numbers, only the residue type could be determined unambiguously.
doi:10.1371/journal.pone.0151431.g003
Taspase1 Loop Conformations
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To verify these regions of secondary structure found in our simulations, we recorded NMR
spectra of the isotope labeled long Taspase 1 loop (Gly178-Asp233). The lower pH value used
for NMR (pH 6.5) compared to CD spectra (pH 7.9) represents a compromise between spectra
quality (slower exchange rate of HN protons leads to better signal intensity) and helix stability
(low pH destabilized the helices in CD spectra; data not shown). Since the transient character
of the secondary structure elements precluded obtaining long range NOEs suitable for struc-
ture calculation, we investigated the appearance of secondary structure elements by the well-
established approach according to Wishart [32]. The negative shift differences found in the
Hα- and Cβ-plots (Fig 5) as well as corresponding stretches of positive values in the Cα plot for
Ile186-Asn199 and Thr211-Gln221 indicate transient helices occurring in the Taspase1 loop.
Notably, the turn element (Lys200-Asp210) between both helices can clearly be identified by
the alternating bars in the plots within this region.
Finally, our data are in line with a helix-turn-helix model generated by homology modeling
of the Taspase1 loop (Fig 6 and S1 file). This model matches the experimentally determined
Fig 4. Spectroscopic analysis and MD simulation of the Taspase1 loop at the C-terminus of the α-
subunit. (a) CD spectra of the long (G178-D233; red) and the short Taspase1 loop (P183-S222; black) show
a helical structure for both peptides. (b) CD spectrum based secondary structure deconvolution using
CDSSTR confirms a higher helical content (green) in the long loop compared to the short loop. Numbers are
given in percent. (c) Three 10 ns molecular dynamics simulations were performed in YASARA starting with a
linear loop peptide. For each amino acid, the time of the respective amino acid in helix, sheet, turn or random
coil conformation is plotted. (d) Representative snapshots of the simulations indicate the formation of helices,
especially around Arg190.
doi:10.1371/journal.pone.0151431.g004
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central turn region with two adjacent helices (Ile186-Leu203 and Asp210-Ser222), as well as a
defined secondary structure element N-terminal of Ser222.
Discussion
Conformational changes of the Taspase1 loop upon activation
The autoproteolytic activation of type 2 asparaginase proteins causes major changes in a loop
fragment at the α-subunit C-terminus and concomitantly greatly increases the flexibility in this
region.
Here, we predicted a helical structure of this loop with a subsequent experimental in vitro
confirmation. Essentially, our data support the model of an α-helical loop with a defined sec-
ondary structure that behaves independently of the Taspase1 core, suggesting a closed state for
the zymogen and an open state for active Taspase1 (S4 Fig). This hypothesis is further sup-
ported by the absence of the respective NMR signals (Ser222, Lys225, Asn227, Ser229-Asp233)
in a cleavage-deficient Asp233A/Thr234A mutant (S5 Fig), indicating a more rigid position of
the very end of the α-subunit C-terminus in the mutant. However, in wild-type Taspase1,
Fig 5. Chemical shift difference analysis of the long Taspase1 loop. Analysis of the chemical shift differences with respect to random coil values for Hα,
Cα, and Cβ shifts of the Taspase1 loop. Helices according to the secondary structure prediction are depicted on top. Note that stretches of negative Hα and Cβ
values, as well as positive Cα values indicate a helical conformation of the respective amino acids.
doi:10.1371/journal.pone.0151431.g005
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opening of the catalytic pocket is likely to be promoted by a repulsion of the positively charged
loop from the also positively charged active site (in S6A and S6B Fig). As the two loops of the
functional Taspase1 homodimer are located at opposite sides of the dimer (S6c Fig), the two
opening events are unlikely promoted by an interaction of the two loops.
While homology modeling of the Taspase1 loop in the context of the full-length enzyme
results in models with two adjacent helices (80% of all models), this is not the case for other
type 2 asparaginases. Their loops appear to be less structured with a short single helix (22% of
the models), interspersed non-adjacent helices (24%), or pure random coil (44%). Given the
good agreement of the in silico with the experimental data, our methods could also be applied
to the flexible parts of other type 2 asparaginases unresolved in the crystal structures. We
expect comparable results by NMR spectroscopy which can aid to confirm predictions and to
understand the structure and role of these loop regions also in other classes of enzymes.
The Taspase1 loop represents a novel anti-cancer target
Taspase1 has been characterized as a disease-related protease [33,34] which is upregulated in a
variety of tumors, including leukemia [35], breast and brain cancer [20]. Over the past years,
Fig 6. Proposed helix-turn-helix structure of Taspase1 loop. The helical character of the proposed structure is confirmed by CD spectroscopy and the
detailed helix-turn-helix structure is supported by NMR spectroscopy data as well as secondary structure prediction. The model shows a helix-turn-helix
motif. NLS amino acids are highlighted in orange, critical NLS residues are displayed in red (according to [15]). The overlay of two possible conformations
indicates flexibility of the termini.
doi:10.1371/journal.pone.0151431.g006
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Taspase1 has moved into the focus as an anticancer drug target, since inactivation has been
shown to block tumor growth and initiation [20,36].
In our proposed helix-turn-helix model of the Taspase1 loop, the interaction of the two heli-
ces brings the bipartite nuclear localization signal (NLS) [15] in close vicinity and forms a con-
tinuous patch (red in Fig 6). Masking of an NLS to prevent catalytic activity was previously
successfully demonstrated with an anti-NLS peptide binding to the HIV-1 integrase NLS, thus
preventing its interaction with importin α and consequently HIV reproduction [37,38]. Hence,
impeding nuclear uptake of Taspase1 is a new approach to inhibit Taspase1 activity, particu-
larly because the maturation event requires a nuclear localization of Taspase1.Therefore, a
decreased nuclear import does not only spatially separate Taspase1 from its nuclear target pro-
teins, but also prevents Taspase1 activation, as cytosolic Taspase1 does not undergo proteolytic
maturation and remains catalytically inactive [15].
Interestingly, Taspase1 is insensitive towards general protease inhibitors, but inhibition by a
natural bisarsenic compound with broad bioactivity [20] as well as weak inhibition by substrate
analog vinyl sulfone peptides have been shown recently [39]. With regard to the high need of
potent Taspase1 inhibitors, the loop might represent a novel target to combat Taspase1-depen-
dent tumors, such as mixed lineage leukemia. As the Taspase1 loop is in proximity of the active
site, inhibitors binding the loop region could act as a clamp to keep the loop in a state similar
to the closed proenzyme, which has already been successfully exploited for caspases [40]. Alter-
natively, the autocatalytic activation event could be prevented by binding of inhibitors, as this
can prevent Taspase1 from adopting the conformation required for the nucleophilic attack ini-
tiating self-cleavage.
These approaches render the Taspase1 loop a promising novel anticancer target, and we
expect that our structural model for this region opens up new approaches for inhibitor design.
Supporting Information
S1 Fig. Example sections of 3D NMR spectra used for sequential assignment. Assignment of
1H-15N HSQC peaks was accomplished with the help of 3D spectra. As an example, the
sequential connections (dashed lines) between Hα and Hβ atoms (top panel), as well as Cα and
Cβ atoms are shown for the assignment of the stretch between Asn227 and Asp233, located at
the tip of the Taspase1 loop. In the upper panel, positive and negative HBHANH peaks are dis-
played in green and red, respectively; HBHACONH signals are displayed in blue. In the lower
panel, positive and negative HNCACB peaks are shown in green and red, respectively; CBCA-
CONH signals are displayed in blue.
(PDF)
S2 Fig. Conservation of the Taspase1 loop sequence. The sequence logo is based on a MUS-
CLE multiple sequence alignment of the loop regions of Taspase1 homologues from 32 species
reveals high conservation. Blue: positively charged amino acids; green: neutral amino acids;
black: hydrophobic amino acids; red: negatively charged amino acids.
(PDF)
S3 Fig. Time dependent appearance of Taspase1 signals in NMR spectra. (a) 1H-15N HSQC
spectra of Taspase1 were recorded right after purification (black) and after one week incuba-
tion at 30°C (red). Peaks of the spectrum right after purification are labeled. (b) SDS-PAGE
analysis of Taspase1 samples after incubation at 37°C shows autocatalytic processing of full-
length (fl) Taspase1 to α and β subunits. Note that no further degradation is visible.
(PDF)
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S4 Fig. Proposed open and closed states of Taspase1 loop. (a)Missing amino acids of the
loop modeled into the crystal structure of the proenzyme (PDB 2a8i). In the proenzyme, the
Taspase1 loop (red and orange) is covalently attached to the active site (green). The loop
amino acids that are structured in the crystal structure of the proenzyme, but not in the pro-
cessed protein are colored in orange. Newly modeled amino acids are displayed in red. (b)
After autocatalytic activation, the loop (red) can leave the active site (green). The model is
based on the structure of active Taspase1 (PDB 2a8j).
(PDF)
S5 Fig. Comparison of wild-type and mutant Taspase1. 1H-15N HSQC spectra of wild-type
Taspase1 (red) and inactive Taspase1 (blue) after 7 days incubation at 30°C. All backbone
peaks of the inactive mutant can also be found in the spectrum of the wild-type protein. The 10
peaks visible only in the wild-type protein are labeled. 9 of these peaks are located in the loop
which is released by autocatalytic activation. A labeling of all assigned peaks can be found in
Fig 3.
(PDF)
S6 Fig. Electrostatic potentials of Taspase1 and location of the Taspase1 loop. (a) Electro-
static potentials were calculated using the Adaptive Poisson-Boltzmann Solver (APBS) apply-
ing the YAMBER2 force field. Positive, neutral, and negative charges are displayed in blue,
gray, and red, respectively. The surface charge of the Taspase1 alpha-subunit C-terminus is
visualized for our proposed loop model and reveals a positive charge. (b) The surface charge of
the Taspase1 core is visualized for the crystal structure of one active Taspase1 heterodimer
(PDB 2a8j). The active site (dashed line) is also positively charged. (c) Location of the loop in
the functional homodimer of Taspase1. Our proposed loop structure was modeled on both
monomers of the Taspase1 proenzyme (PDB 2a8i). Monomer 1 is depicted in orange with its
loop in green, monomer 2 in red with its loop in blue.
(PDF)
S1 File. PDB coordinates of Fig 6.
(PDB)
S1 Table. Parameters for homology modeling in YASARA.
(PDF)
S2 Table. NMR shift values of Taspase1 full-length, given in ppm.
(PDF)
S3 Table. NMR shift values of the Taspase1 loop, given in ppm.
(PDF)
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